These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 18041647)

  • 1. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
    Huang HM; Chiou HY; Chang JL
    J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A
    Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory effect of Smad7 gene on MAPK signal pathway in malignant transformation of immortalized human bronchial epithelial BEP2D cells].
    Wang L; Huo YY; Zhang KT; Wang Y; Xiang XQ; Hu YC; Yu G; Li G; Mi C; Wu DC
    Ai Zheng; 2005 Sep; 24(9):1080-4. PubMed ID: 16159429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
    Moosavi MA; Yazdanparast R; Lotfi A
    Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells.
    Moon HJ; Jeon ES; Kim YM; Lee MJ; Oh CK; Kim JH
    Int J Biochem Cell Biol; 2007; 39(6):1224-34. PubMed ID: 17481939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
    Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
    Shelly C; Petruzzelli L; Herrera R
    Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
    Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
    Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
    Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
    Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
    Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
    Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
    Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Fuchs R; Schraml E; Leitinger G; Stelzer I; Allard N; Haas HS; Schauenstein K; Sadjak A
    Exp Cell Res; 2011 Oct; 317(16):2239-51. PubMed ID: 21781962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
    Chen CH; Lin JY; Liu FH; Chang JL; Huang HM
    Ann Hematol; 2008 Mar; 87(3):175-82. PubMed ID: 17929017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
    Kucukkaya B; Arslan DO; Kan B
    Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.